Results 271 to 280 of about 58,944 (343)

Retinopathy of prematurity in the UK II: Audit of national guidelines for screening and treatment [PDF]

, 2002
Alistair R. Fielder, L Haines, Ross Scrivener, Andrew R. Wilkinson, J. Pollock   +4 more
openalex   +1 more source

Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 2920-2939, June 2025.
Abstract Glycaemic therapy in type 1 diabetes (T1D) is focused on insulin, with the majority of studies investigating different insulin preparations, delivery devices and dosing accuracy methods. While insulin deficiency is the key mechanism for hyperglycaemia in T1D, individuals with this condition can also develop insulin resistance (IR), making ...
Ahmad M. Rajab, Sam Pearson, Ramzi A. Ajjan   +2 more
wiley   +1 more source

Development and validation of a multivariate nomogram for predicting retinopathy of prematurity in infants with gestational age ≤34 weeks. [PDF]

Front Pediatr
Shen L, Zheng R, Sun X, Chen S.
europepmc   +1 more source

Retinopathy of prematurity: recent advances in our understanding [PDF]

, 2002
Catherine Wheatley
openalex   +1 more source

Diabetes self‐care activities and its correlates in patients with diabetic neuropathy

Journal of Clinical Nursing, Volume 34, Issue 6, Page 2163-2170, June 2025.
Abstract Background Diabetic neuropathy is the most common chronic complication observed in patients with diabetes and has significant clinical implications, such as decreased quality of life and increased morbidity and mortality rates. Studies on the factors affecting diabetes self‐care activities pertaining to patients with diabetic neuropathy are ...
Younhee Kang, Inkyung Park
wiley   +1 more source

Metabolic correlations between kidney and eye in a mouse model of oxygen-induced retinopathy and retinopathy of prematurity. [PDF]

BMJ Open Ophthalmol
Yang Y, Dong L, Qi H, Zhang Y, Zhang Y, Sun J, Chai X, Lu X, Fan Z, Wu D, Zhang G, Lei H.   +11 more
europepmc   +1 more source

Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity

Pediatrics, 2016
J. Morin, T. Luu, R. Superstein, L. Ospina, F. Lefebvre, M. Simard, V. Shah, P. Shah, E. Kelly   +8 more
semanticscholar   +1 more source

Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes

Journal of Internal Medicine, Volume 297, Issue 6, Page 584-607, June 2025.
Abstract Cardiometabolic diseases—including Type 2 diabetes and obesity—remain leading causes of global mortality. Recent advancements in metabolomics have facilitated the identification of metabolites that are integral to the development of insulin resistance, a characteristic feature of cardiometabolic disease. Key metabolites, such as branched‐chain
David Rizo‐Roca, John D. Henderson, Juleen R. Zierath   +2 more
wiley   +1 more source

AI-Enabled Screening for Retinopathy of Prematurity in Low-Resource Settings.

JAMA Netw Open
Ortiz A, Patiño S, Torres J, Mármol J, Serafin C, Dodhia R, Saidman G, Schbib V, Peña B, Monteoliva G, Martinez-Castellanos MA, Weeks WB, Lavista Ferres JM.   +12 more
europepmc   +1 more source

CHARACTERISTICS OF "NOTCH" IN RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL RANIBIZUMAB MONOTHERAPY. [PDF]

Retina
Zhang F, Zou Q, Liu Q, You Z.
europepmc   +1 more source